This report was originally published May 14, and updated May 18 to include additional information from the UKCMRI.

By Alex Philippidis

NEW YORK (GenomeWeb News) — The planned UK Centre for Medical Research and Innovation has begun soliciting resumes for its first director and chief executive who would be "responsible for all aspects of its operations" — a sign that the controversial project continues to move forward following the UK's recent change of government.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.